Clindaman

Clindamycin 150mg/mL (300 mg/2mL) Solution for Injection (I.M./I.V.)

Clindaman

Clindamycin 150mg/mL (300 mg/2mL) Solution for Injection (I.M./I.V.)

Enquire now!

    Description

    Clindamycin Phosphate is a clear colorless solution for injection filled in a clear glass ampoule.

    Formulation:

    Each mL contains 178. 23 mg clindamycin phosphate equivalent to 150 mg clindamycin.

    Packaging/Availability:

    Box of 10 x 2mL ampoules, (150mg/mL (300mg/2mL)

    Indications & Dosage

    Indications:

    For treatment of bacterial infections caused by susceptible microorganism i.e.
    1. As an adjunctive treatment of chronic bone and joint infections, and acute hematogenous osteomyelitis caused by staphylococci.
    2. Female pelvic infections, including endometritis, non-gonococcal tubo-ovarian abscess, pelvic cellulitis, and postsurgical vaginal cuff infections caused by susceptible anaerobes.
    3. Intra-abdominal infections such as peritonitis and abscesses caused by susceptible anaerobes.
    4. Pneumonia including serious respiratory tract infections (such as empyema, pneumonitis, and lung abscesses) caused by susceptible anaerobes.
    5. Septicemia caused by streptococci and staphylococci.
    6. Skin and soft tissue infections caused by susceptible anaerobes, streptococci, and staphylococci.

    Dosage and Administration

    Usual adult and adolescent dose:
    Intramuscular or intravenous
    – Serious infections: 600-1200 mg/day in 2,3 or 4 equal doses
    – More severe infections: 1200-1700 mg/day in 2,3 or 4 equal doses
    – For more serious infections, these doses may have to be increased. In life-threatening situations due to
    either aerobes or anaerobes these doses may be increased. Doses of as much as 4800 mg daily have been
    given intravenously to adults.
    (Single intramuscular injections of greater than 600 mg are not recommended and dosage should not exceed 2.7
    gm daily)

    Usual pediatric dose:
    Intramuscular or intravenous
    – 20 to 40 mg/kg/day in 3 or 4 equal doses. The higher doses would be used for more severe infections. As an
    alternative to dosing on body weight basis, pediatric patients may be dosed on the basis of square meters body
    surface: 350mg/m2/day for serious infections and 450 mg/m2/day for more severe infections.

    See insert for complete information

    Distribution

    Distributed by:
    NEO CARE PHILIPPINES
    #2 Pinagkurusan,
    Alitagtag, Batangas

    Imported by:
    EURO-CARE PRODUCTS PHILIPPINES
    Tinio St., San Nicolas,
    Gapan City, Nueva Ecija

    Manufactured by:
    VESCO PHARMACEUTICAL CO., LTD.
    Bangkok, Thailand

    Reviews

    There are no reviews yet.

    Be the first to review “Clindaman”

    Your email address will not be published. Required fields are marked *

    Enquire now!